Form 4 for PCTY Paylocity Holding Corp
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0001591698-25-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-02-19 | 2025-02-18 | PCTY | Beauchamp Steven R | Executive COB, Dir | G - Gift | $0.00 | +15.0K | 235.0K | +7% | $0 |
| MI | 2025-02-19 | 2025-02-14+ | PCTY | Beauchamp Steven R | Executive COB, Dir | S - Sale | $217.12 | -22.5K | 0 | -100% | -$4.89M |
| M | 2025-02-19 | 2025-02-14 | PCTY | Beauchamp Steven R | Executive COB, Dir | S - Sale | $217.22 | -30.0K | 1.57M | -2% | -$6.52M |
| 2025-02-19 | 2025-02-17 | PCTY | Beauchamp Steven R | Executive COB, Dir | F - Tax | $216.96 | -1,666 | 1.57M | -0.1% | -$361.5K | |
| 2025-02-19 | 2025-02-18 | PCTY | Beauchamp Steven R | Executive COB, Dir | G - Gift | $0.00 | -15.0K | 1.55M | -1.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2025-02-18 | G | A | 15,000 | $0.00 | 235,000 | I by IRIE Foundation | — | — | (F7) Shares transferred by the reporting person as a gift to the IRIE Family Trust for the benefit of the reporting person's children and for which the reporting person's spouse serves as trustee. |
| 2 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 500 | $215.02 | 22,000 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.41 to $215.41, inclusive. |
| 3 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 3,598 | $216.79 | 18,402 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $215.98 to $216.97, inclusive. |
| 4 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 5,620 | $217.39 | 12,782 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $217.01 to $217.98, inclusive. |
| 5 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 1,532 | $218.28 | 11,250 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $218.02 to $218.76, inclusive. |
| 6 | Common | Common Stock, par value $0.001 | 2025-02-18 | S | D | 1,886 | $216.01 | 9,364 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F12) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $215.32 to $216.28, inclusive. |
| 7 | Common | Common Stock, par value $0.001 | 2025-02-18 | S | D | 5,941 | $216.91 | 3,423 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F13) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $216.37 to $217.37, inclusive. |
| 8 | Common | Common Stock, par value $0.001 | 2025-02-18 | S | D | 3,423 | $217.77 | 0 | I | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F14) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $217.40 to $218.03, inclusive. |
| 9 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 1,000 | $215.02 | 1,600,079 | D by IRIE Family Trust | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.38 to $215.30, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13 and 14 of this Form 4. |
| 10 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 1,863 | $216.03 | 1,598,216 | D by IRIE Foundation | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $215.46 to $216.45, inclusive. |
| 11 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 20,005 | $217.14 | 1,578,211 | D by IRIE Foundation | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $216.55 to $217.54, inclusive. |
| 12 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 6,764 | $218.03 | 1,571,447 | D by IRIE Foundation | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $217.58 to $218.57, inclusive. |
| 13 | Common | Common Stock, par value $0.001 | 2025-02-14 | S | D | 368 | $218.68 | 1,571,079 | D by IRIE Foundation | — | — | (F1) The transaction indicated was conducted under an approved 10b5-1 Plan adopted on November 15, 2024. (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $218.65 to $218.79, inclusive. |
| 14 | Common | Common Stock, par value $0.001 | 2025-02-17 | F | D | 1,666 | $216.96 | 1,569,413 | D by IRIE Foundation | — | — | |
| 15 | Common | Common Stock, par value $0.001 | 2025-02-18 | G | D | 15,000 | $0.00 | 1,554,413 | D by IRIE Foundation | — | — | (F7) Shares transferred by the reporting person as a gift to the IRIE Family Trust for the benefit of the reporting person's children and for which the reporting person's spouse serves as trustee. |